Digital Diabetes Management Market Size Development Trends, Competitive Landscape and Key Regions 2030 Global Market Insights adds a new report Global Digital Diabetes Management Market Research Report for the period of 2022-2030 that shows the growth of the market is rising at a Steady CAGR to 2030. Strategic partnerships among leading players in the space of diabetes treatment and diagnosis is expected to consolidate growth of the market further. In 2021, French medical devices firm, BIOCORP, collaborated with world-leading diabetes care provider, Novo Nordisk, over smart insulin pens. The collaboration aimed at developing and distributing Mallya smart add-on device, which is a Bluetooth-enabled smart device for pen injectors such as Novo Nordisk FlexTouch pen that is commonly used by diabetic patients. Browse key industry insights spread across 213 pages with 344 market data tables & 15 figures & charts from the report, “Digital Diabetes Management Market Analysis By Product Type ({Devices [Smart Blood Glucose Meters, Smart CGM, Smart Insulin Pumps & Patches, Smart Insulin Pens], Device Type [Wearable, Handheld]}, Services {Diabetes Apps, Software}), Patient Type (Type 1, Type 2), End-Use (Hospitals, Home settings, Diagnostic Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 – 2030” in detail along with the table of contents: https://www.gminsights.com/industry-analysis/digital-diabetes-management-market The global digital diabetes management market is bifurcated into product type, patient type, end-use, and region. Based on product type, the digital diabetes management industry is divided into services, devices, and device type. The device segment is further sectioned into smart CGM, smart insulin pens, smart blood glucose meters, and smart insulin pumps. The device type is bifurcated into wearable, handheld. Services product type segment is further sub-segmented into software and apps. Among these, services product segment is estimated to grow at a CAGR of around 19.6% through the forecast timeline, driven by the development of advanced software and mobile applications that facilitate real time access to patient data. Advantages such as continuous monitoring and management of large volumes of patient data will pave the way for segment growth. With respect to patient type, the digital diabetes management market is categorized into type 1 diabetes, and type 2 diabetes. In 2021, the type 2 diabetes segment accounted for more than 90% of overall digital diabetes management market share. Key driving factors that are fueling the segment growth include increasing type 2 diabetes patient pool, rapid adoption of digital technologies for better diabetes management and increasing preference for smart devices to monitor blood glucose and insulin dosage.
© 2022 All Rights Reserved
www.gminsights.com